In-hospital outcomes after SAVR or TAVI in patients with severe aortic stenosis.

Aortic stenosis Surgical aortic valve replacement Transcatheter aortic valve implantation

Journal

Cardiovascular intervention and therapeutics

ISSN: 1868-4297

Titre abrégé: Cardiovasc Interv Ther

Pays: Japan

ID NLM: 101522043

Informations de publication

Date de publication:
22 Jun 2023

Historique:

received: 08 02 2023

accepted: 06 06 2023

medline: 23 6 2023

pubmed: 23 6 2023

entrez: 22 6 2023

Statut: aheadofprint

Résumé

There were no data comparing the in-hospital outcomes after transcatheter aortic valve implantation (TAVI) with those after surgical aortic valve replacement (SAVR) in Japan. Among consecutive patients with severe AS between April 2018 and December 2020 in the CURRENT AS Registry-2, we identified 1714 patients who underwent aortic valve replacement (TAVI group: 1134 patients, and SAVR group: 580 patients). Patients in the TAVI group were much older (84.4 versus 73.6 years, P < 0.001) and more often had comorbidities than those in the SAVR group. In-hospital death rate was numerically lower in the TAVI group than in the SAVR group (0.6% versus 2.2%). After excluding patients with dialysis, in-hospital death rate was very low and comparable in the TAVI and SAVR groups (0.6% versus 0.8%). The rates of major bleeding and new-onset atrial fibrillation during index hospitalization were higher after SAVR than after TAVI (72% versus 20%, and 26% versus 4.6%, respectively), while the rate of pacemaker implantation was higher after TAVI than after SAVR (8.1% versus 2.4%). Regarding the echocardiographic data at discharge, the prevalence of patient-prosthesis mismatch was lower in the TAVI group than in the SAVR group (moderate: 9.0% versus 26%, and severe: 2.6% versus 4.8%). In this real-world data in Japan, TAVI compared with SAVR was chosen in much older patients with more comorbidities with severe AS. In-hospital death rate was numerically lower in the TAVI group than in the SAVR group.

Identifiants

DOI: 10.1007/s12928-023-00942-x PMID: 37349628

pubmed: 37349628

doi: 10.1007/s12928-023-00942-x

pii: 10.1007/s12928-023-00942-x

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, Schmitz W, Kübler W. The effect of aortic valve replacement on survival. Circulation. 1982;66(5):1105–10. https://doi.org/10.1161/01.CIR.66.5.1105 .

Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, PARTNER Trial Investigators, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

doi: 10.1056/NEJMoa1008232 pubmed: 20961243

Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, PARTNER Trial Investigators, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

doi: 10.1056/NEJMoa1103510 pubmed: 21639811

Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.

doi: 10.1056/NEJMoa1514616 pubmed: 27040324

Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706–15.

doi: 10.1056/NEJMoa1816885 pubmed: 30883053

Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–705.

doi: 10.1056/NEJMoa1814052 pubmed: 30883058

Carroll JD, Mack MJ, Vemulapalli S, Herrmann HC, Gleason TG, Hanzel G, et al. STS-ACC TVT registry of Transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;76:2492–516.

doi: 10.1016/j.jacc.2020.09.595 pubmed: 33213729

Mori M, Gupta A, Wang Y, Vahl T, Nazif T, Kirtane AJ, et al. Trends in transcatheter and surgical aortic valve replacement among older adults in the United States. J Am Coll Cardiol. 2021;78:2161–72.

doi: 10.1016/j.jacc.2021.09.855 pubmed: 34823659

Kamon T, Kaneko H, Kiriyama H, Itoh H, Fujiu K, Kumazawa R, et al. Transcatheter aortic valve implantation and surgical aortic valve replacement for aortic stenosis in Japan - analysis of a nationwide inpatient database. Circ Rep. 2020;2(12):753–8.

doi: 10.1253/circrep.CR-20-0116 pubmed: 33693206 pmcid: 7937519

Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, CURRENT AS Registry Investigators, et al. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2015;66:2827–38.

doi: 10.1016/j.jacc.2015.10.001 pubmed: 26477634

Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, et al, (2020) CURRENT AS Registry-2 Investigators. Rationale, Design, and Baseline Characteristics of the CURRENT AS Registry-2. Circ J 86 (11) 1769–1776.

De Sciscio P, Brubert J, De Sciscio M, Serrani M, Stasiak J, Moggridge GD. Quantifying the shift toward transcatheter aortic valve replacement in low-risk patients. Circ Cardiovasc Qual Outcomes. 2017;10(6): e003287.

doi: 10.1161/CIRCOUTCOMES.116.003287 pubmed: 28600455

Thourani VH, Suri RM, Gunter RL, Sheng S, O’Brien SM, Ailawadi G, et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. Ann Thorac Surg. 2015;99:55–61.

doi: 10.1016/j.athoracsur.2014.06.050 pubmed: 25442986

Takimoto S, Saito N, Minakata K, Shirai S, Isotani A, Arai Y, et al. Favorable clinical outcomes of transcatheter aortic valve implantation in Japanese patients - first report from the post-approval K-TAVI registry. Circ J. 2016;81:103–9.

doi: 10.1253/circj.CJ-16-0546 pubmed: 27916776

Herrmann HC, Daneshvar SA, Fonarow GC, Stebbins A, Vemulapalli S, Desai ND, et al. Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement: From the STS/ACC TVT registry. J Am Coll Cardiol. 2018;72:2701–11.

doi: 10.1016/j.jacc.2018.09.001 pubmed: 30257798

Head SJ, Mokhles MM, Osnabrugge RLJ, Pibarot P, MacK MJ, Takkenberg JJM, et al. The impact of prosthesispatient mismatch on long-term survival after aortic valve replacement: A systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J. 2012;33:1518–29.

doi: 10.1093/eurheartj/ehs003 pubmed: 22408037

Yamauchi T, Yamamoto H, Miyata H, Kobayashi J, Masai T, Motomura N. Surgical aortic valve replacement for aortic stenosis in dialysis patients - analysis of japan cardiovascular surgery database. Circ J. 2020;84:1271–6.

doi: 10.1253/circj.CJ-20-0042 pubmed: 32612017

Szerlip M, Zajarias A, Vemalapalli S, Brennan M, Dai D, Maniar H, et al. Transcatheter aortic valve replacement in patients with end-stage renal disease. J Am Coll Cardiol. 2019;73:2806–15.

doi: 10.1016/j.jacc.2019.03.496 pubmed: 31171086

Vincent F, Ternacle J, Denimal T, et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Circulation. 2021;143(10):1043–61.

doi: 10.1161/CIRCULATIONAHA.120.048048 pubmed: 33683945